PathAI Receives FDA Clearance for AISight Dx Platform
PathAI has received FDA 510(k) clearance for its AISight Dx digital pathology platform, enabling its use in primary diagnosis.
PathAI has received FDA 510(k) clearance for its AISight Dx digital pathology platform, enabling its use in primary diagnosis.
Roche’s Digital Pathology Dx platform received additional FDA clearance, now incorporating the VENTANA DP 600 slide scanner.
Concentriq Embeddings allows pathology and data science teams to generate high-dimensional numerical representations from whole slide images.
Proscia has launched an updated version of Concentriq AP, enhancing AI-enabled pathology workflows to improve understanding of major cancers.
Stellaris is designed to significantly improve how scientists are able to capture three-dimensional images of living cells and tissues.
Roche's VENTANA DP 200 whole slide imaging system has received FDA clearance for diagnosing patients through digital pathology.